|
Chỉ định và Liều dùng
Intramuscular
Susceptible infections Adult: 2 g/day in 2 divided doses. Child: 50-100 mg/kg/day in 2-3 divided doses. Intravenous Susceptible infections Adult: 2-6 g/day in 2-3 divided doses. Child: 50-100 mg/kg/day in 2-3 divided doses. Intravenous Meningitis Child: 100 mg/kg as loading dose.
|
||||||||
|
Suy thận
Intravenous:
Susceptible infections: Haemodialysis patient: 15 mg/kg at end of each dialysis.
|
||||||||
|
Chống chỉ định
Hypersensitivity.
|
||||||||
|
Thận trọng
Monitor bleeding time and give prophylaxis with vitamin K. Pregnancy and lactation. Renal impairment.
|
||||||||
|
Tác dụng không mong muốn
Hypoprothrombinaemia, serious bleeding episodes. Fever, pain at inj site, diarrhoea, cutaneous eruption, eosinophilia, leucopenia, thrombocytopenia.
|
||||||||
|
Tương tác
Disulfiram-like reaction with alcohol.
|
||||||||
|
Ảnh hưởng đến kết quả xét nghiệm
False-positive results for direct Coombs' test.
|
||||||||
|
Tác dụng
Description:
Mechanism of Action: Latamoxef is an oxacephalosporin with antimicrobial spectrum of activity similar to 3rd generation cephalosporins. It also inhibits beta-lactamases. Pharmacokinetics: Absorption: Well absorbed (IM). Distribution: Enters the CSF. Metabolism: Not metabolised. Excretion: Via urine (75%, as unchanged drug) and via biliary tract; 2 hr (half-life). |
||||||||
|
Phân loại MIMS
|
Đăng xuất
